• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的残疾评定量表。

Disability rating scales in multiple sclerosis.

作者信息

Kurtzke J F

出版信息

Ann N Y Acad Sci. 1984;436:347-60. doi: 10.1111/j.1749-6632.1984.tb14805.x.

DOI:10.1111/j.1749-6632.1984.tb14805.x
PMID:6598017
Abstract

The International Federation of Multiple Sclerosis Societies has been attempting to define a Minimal Data Set for multiple sclerosis following the tripartite scheme of the World Health Organization, with one rating scheme for neurologic signs, one for physical disabilities, and one for the societal impact of the disease. Current recommendations are the Disability Status Scale or the Expanded DSS plus Functional Systems for the first, Incapacity Status Scale of 16 items for the second, and Environmental Status Scale of 7 items for the third. All are graded in an ordinal (rank) scale from 0 (normal) with larger numbers for greater involvement. ISS scores range from 0-4 and ESS from 0-5 for each item. The only part of this scheme useful for measurement in clinical trials is the (E)DSS + FS. The DSS ranges from 0-10; EDSS subdivides each DSS grade 1-9 into two. FS are pyramidal, cerebellar, brain stem, sensory, bowel and bladder, visual, cerebral, or other; all save the last are graded 0-5 or 0-6. The DSS correlates well with both frequency and severity of involvement in all FS, which in turn represent a coded standard neurologic examination.

摘要

国际多发性硬化症协会一直试图按照世界卫生组织的三方方案,为多发性硬化症定义一个最小数据集,其中一个评分方案用于神经系统体征,一个用于身体残疾,另一个用于疾病的社会影响。目前的建议是,第一个采用残疾状态量表或扩展残疾状态量表加功能系统,第二个采用16项的失能状态量表,第三个采用7项的环境状态量表。所有这些都采用顺序(等级)量表进行分级,从0(正常)开始,数值越大表示受累程度越高。每个项目的失能状态量表(ISS)分数范围为0至4,环境状态量表(ESS)分数范围为0至5。该方案中对临床试验测量有用的唯一部分是扩展残疾状态量表(EDSS)加功能系统(FS)。残疾状态量表(DSS)范围为0至10;扩展残疾状态量表(EDSS)将1至9级的每个DSS等级再细分为两个等级。功能系统包括锥体束、小脑、脑干、感觉、肠道和膀胱、视觉、大脑或其他;除最后一项外,所有项目的分级均为0至5或0至6。残疾状态量表(DSS)与所有功能系统中受累的频率和严重程度都有很好的相关性,而功能系统又代表了一种编码的标准神经系统检查。

相似文献

1
Disability rating scales in multiple sclerosis.多发性硬化症的残疾评定量表。
Ann N Y Acad Sci. 1984;436:347-60. doi: 10.1111/j.1749-6632.1984.tb14805.x.
2
Historical and clinical perspectives of the expanded disability status scale.扩展残疾状态量表的历史与临床视角
Neuroepidemiology. 2008;31(1):1-9. doi: 10.1159/000136645. Epub 2008 Jun 6.
3
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).评估多发性硬化症的神经功能损伤:扩展残疾状态量表(EDSS)
Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
4
On the origin of EDSS.关于扩展残疾状态量表(EDSS)的起源
Mult Scler Relat Disord. 2015 Mar;4(2):95-103. doi: 10.1016/j.msard.2015.02.003. Epub 2015 Feb 24.
5
Clinical definition for multiple sclerosis treatment trials.多发性硬化症治疗试验的临床定义。
Ann Neurol. 1994;36 Suppl:S73-9. doi: 10.1002/ana.410360717.
6
Scales for rating impairment in multiple sclerosis: a critique.多发性硬化症损伤评定量表:一项批判性分析。
Neurology. 1988 Nov;38(11):1793-8. doi: 10.1212/wnl.38.11.1793.
7
[The Minimal Record of Disability and multiple sclerosis. Results of the evaluation of 200 patients].
Rev Neurol (Paris). 1988;144(12):805-16.
8
Clinical scales for multiple sclerosis.多发性硬化症的临床量表
J Neurol Sci. 1996 Jan;135(1):1-9. doi: 10.1016/0022-510x(95)00261-y.
9
Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test.自我管理的扩展残疾状态量表及其功能系统评分与医生实施的测试相关性良好。
Mult Scler. 2001 Jun;7(3):201-6. doi: 10.1177/135245850100700311.
10
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis.多发性硬化症患者残疾最小记录自我评估的准确性
Acta Neurol Scand. 1993 Jan;87(1):43-6. doi: 10.1111/j.1600-0404.1993.tb04073.x.

引用本文的文献

1
The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients.轴突损伤生物标志物与骨桥蛋白在诊断时的关联可能对新诊断的多发性硬化症患者有用。
Neurol Int. 2025 Jul 17;17(7):110. doi: 10.3390/neurolint17070110.
2
Integration of the expanded disability status scale with ambulation, visual and cognitive tests.将扩展残疾状态量表与活动能力、视觉和认知测试相结合。
Neurol Sci. 2024 Oct;45(10):4799-4805. doi: 10.1007/s10072-024-07559-9. Epub 2024 Apr 30.
3
Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation.
炎症性肠病残疾指数是一种在英语国家医院实践中对残疾情况进行有效且可靠评估的指标,并且能够预测长期治疗升级的需求。
Frontline Gastroenterol. 2023 Nov 10;15(2):130-136. doi: 10.1136/flgastro-2023-102428. eCollection 2024 Mar.
4
Validated, Quantitative, Machine Learning-Generated Neurologic Assessment of Multiple Sclerosis Using a Mobile Application.使用移动应用程序对多发性硬化症进行验证的、定量的、机器学习生成的神经学评估。
Int J MS Care. 2024 Mar-Apr;26(2):69-74. doi: 10.7224/1537-2073.2023-009. Epub 2024 Mar 6.
5
Longitudinal Effects of Sex, Aging, and Multiple Sclerosis Diagnosis on Function.性别、衰老和多发性硬化症诊断对功能的纵向影响。
Nurs Res. 2023;72(4):281-291. doi: 10.1097/NNR.0000000000000656.
6
Apparent changes in the epidemiology and severity of multiple sclerosis.多发性硬化症的流行病学和严重程度的明显变化。
Nat Rev Neurol. 2021 Nov;17(11):676-688. doi: 10.1038/s41582-021-00556-y. Epub 2021 Sep 28.
7
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.自体造血干细胞移植作为“侵袭性”多发性硬化症患者的一线疾病修正治疗。
Mult Scler. 2021 Jul;27(8):1198-1204. doi: 10.1177/1352458520985238. Epub 2021 Feb 10.
8
Technology-enabled assessments to enhance multiple sclerosis clinical care and research.借助技术的评估以改善多发性硬化症的临床护理与研究。
Neurol Clin Pract. 2020 Jun;10(3):222-231. doi: 10.1212/CPJ.0000000000000710.
9
Brain Function Assessment of Patients with Multiple Sclerosis in the Expanded Disability Status Scale: A Proposal for Modification.扩展残疾状态量表中多发性硬化症患者的脑功能评估:一项修改建议
Int J MS Care. 2020 Jan-Feb;22(1):31-35. doi: 10.7224/1537-2073.2018-084.
10
The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients.FTO 基因多态性 rs9939609 与多发性硬化症患者的肥胖和残疾有关。
Sci Rep. 2019 Dec 13;9(1):19071. doi: 10.1038/s41598-019-55742-2.